SELLAS Life Sciences Group Inc (SLS)
1.34
+0.06
(+4.69%)
USD |
NASDAQ |
May 02, 16:00
1.35
+0.01
(+0.75%)
Pre-Market: 08:08
SELLAS Life Sciences Group 1 Year Total Returns (Daily): -8.84% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -8.84% |
May 01, 2024 | -14.09% |
April 30, 2024 | -11.74% |
April 29, 2024 | -13.88% |
April 26, 2024 | 0.00% |
April 25, 2024 | 9.35% |
April 24, 2024 | 14.07% |
April 23, 2024 | 16.43% |
April 22, 2024 | 10.00% |
April 19, 2024 | -1.28% |
April 18, 2024 | -5.00% |
April 17, 2024 | -15.06% |
April 16, 2024 | -15.18% |
April 15, 2024 | -17.05% |
April 12, 2024 | -10.67% |
April 11, 2024 | -10.83% |
April 10, 2024 | -6.71% |
April 09, 2024 | -9.68% |
April 08, 2024 | -6.77% |
April 05, 2024 | -8.22% |
April 04, 2024 | -16.23% |
April 03, 2024 | -19.14% |
April 02, 2024 | -17.48% |
April 01, 2024 | -25.17% |
March 28, 2024 | -14.41% |
Date | Value |
---|---|
March 27, 2024 | -13.81% |
March 26, 2024 | -13.82% |
March 25, 2024 | -15.45% |
March 22, 2024 | -13.71% |
March 21, 2024 | -22.31% |
March 20, 2024 | -18.75% |
March 19, 2024 | -22.22% |
March 18, 2024 | -22.22% |
March 15, 2024 | -20.29% |
March 14, 2024 | 9.15% |
March 13, 2024 | 12.88% |
March 12, 2024 | 0.73% |
March 11, 2024 | -1.09% |
March 08, 2024 | -14.86% |
March 07, 2024 | -15.48% |
March 06, 2024 | -23.57% |
March 05, 2024 | -33.96% |
March 04, 2024 | -35.22% |
March 01, 2024 | -36.31% |
February 29, 2024 | -40.24% |
February 28, 2024 | -40.24% |
February 27, 2024 | -41.62% |
February 26, 2024 | -40.35% |
February 23, 2024 | -74.63% |
February 22, 2024 | -76.83% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.43%
Minimum
Mar 20 2020
543.4%
Maximum
Mar 17 2021
-3.31%
Average
-57.54%
Median
Dec 05 2023
1 Year Total Returns (Daily) Benchmarks
Geron Corp | 59.27% |
Immuneering Corp | -82.55% |
Protagonist Therapeutics Inc | 7.63% |
Akebia Therapeutics Inc | 48.17% |
Moderna Inc | -4.39% |